Glen Eagle Advisors’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-750
Closed -$49.9K 972
2021
Q3
$49.9K Hold
750
0.01% 373
2021
Q2
$47.3K Sell
750
-100
-12% -$5.63K 0.01% 385
2021
Q1
$44.2K Buy
850
+100
+13% +$6.08K 0.02% 365
2020
Q4
$32.9K Hold
750
0.01% 394
2020
Q3
$35.5K Sell
750
-150
-17% -$6.08K 0.02% 352
2020
Q2
$27.2K Hold
900
0.01% 386
2020
Q1
$15.4K Hold
900
0.01% 446
2019
Q4
$14.8K Buy
900
+100
+13% +$1.49K 0.01% 510
2019
Q3
$13.1K Hold
800
0.01% 470
2019
Q2
$14.7K Hold
800
0.01% 441
2019
Q1
$10.3K Buy
800
+200
+33% +$2.17K 0.01% 477
2018
Q4
$6.62K Hold
600
0.01% 520
2018
Q3
$7.69K Buy
+600
New +$8.56K 0.01% 501

Other funds holding CYRX

Glen Eagle Advisors's CYRX Position: Q4 2021 in Review

Glen Eagle Advisors sold out of CryoPort (CYRX) in Q4 2021, closing a stake of 750 shares — an estimated $49.9K sold.

Glen Eagle Advisors first reported a position in CYRX in Q3 2018 and held it in 13 quarters. The position peaked at $49.9K in Q3 2021. 227 funds tracked by Wall St. Rank hold CYRX as of Q4 2021.

  • Glen Eagle Advisors reported no remaining CryoPort position as of Q4 2021 after selling out during the quarter.
  • Glen Eagle Advisors sold 750 CryoPort shares in Q4 2021, an estimated $49.9K.
  • Glen Eagle Advisors first reported a position in CryoPort in Q3 2018 and held it in 13 quarters.
  • Glen Eagle Advisors's CryoPort position peaked at $49.9K in Q3 2021.
  • 227 funds tracked by Wall St. Rank held CryoPort as of Q4 2021.

Based on Glen Eagle Advisors's 13F filing for Q4 2021, filed 13 Aug 2024.